CCRN•benzinga•September 14, 2022 at 01:59 PM

Cross Country Healthcare 8K Filing Revising Its Guidance For Q3 With Respect To Revenue, Adj. EBITDA, And Adj. EPS Guidance; Sees Q3 2022 Revenue $615M-$625M; Sees Q3 2022 Adj. EPS $0.90-$1.00; Q3 SHR View $0.91, Rev View $610.5M

No summary available.

Read the full article from the original source for complete details and context.

Article published on September 14, 2022 by benzinga